199 related articles for article (PubMed ID: 26947609)
21. Selective sigma-1 receptor antagonists for the treatment of pain.
Almansa C; Vela JM
Future Med Chem; 2014 Jun; 6(10):1179-99. PubMed ID: 25078137
[TBL] [Abstract][Full Text] [Related]
22. Tricyclic Triazoles as σ
Díaz JL; Cuevas F; Oliva AI; Font D; Sarmentero MÁ; Álvarez-Bercedo P; López-Valbuena JM; Pericàs MA; Enrech R; Montero A; Yeste S; Vidal-Torres A; Álvarez I; Pérez P; Cendán CM; Cobos EJ; Vela JM; Almansa C
J Med Chem; 2021 Apr; 64(8):5157-5170. PubMed ID: 33826322
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
[TBL] [Abstract][Full Text] [Related]
24. Novel Sigma-1 receptor antagonists: from opioids to small molecules: what is new?
Arena E; Dichiara M; Floresta G; Parenti C; Marrazzo A; Pittalà V; Amata E; Prezzavento O
Future Med Chem; 2018 Jan; 10(2):231-256. PubMed ID: 29185346
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands.
Zampieri D; Laurini E; Vio L; Golob S; Fermeglia M; Pricl S; Mamolo MG
Bioorg Med Chem Lett; 2014 Feb; 24(4):1021-5. PubMed ID: 24486131
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of N‑(benzylpiperidinyl)‑4‑fluorobenzamide: A haloperidol analog that reduces neuropathic nociception via σ
Déciga-Campos M; Melo-Hernández LA; Torres-Gómez H; Wünsch B; Schepmann D; González-Trujano ME; Espinosa-Juárez J; López-Muñoz FJ; Navarrete-Vázquez G
Life Sci; 2020 Mar; 245():117348. PubMed ID: 31981633
[TBL] [Abstract][Full Text] [Related]
27. Novel highly potent and selective sigma 1 receptor antagonists related to spipethiane.
Piergentili A; Amantini C; Del Bello F; Giannella M; Mattioli L; Palmery M; Perfumi M; Pigini M; Santoni G; Tucci P; Zotti M; Quaglia W
J Med Chem; 2010 Feb; 53(3):1261-9. PubMed ID: 20067271
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and pharmacological evaluation of a potent and selective σ1 receptor antagonist with high antiallodynic activity.
Utech T; Köhler J; Buschmann H; Holenz J; Vela JM; Wünsch B
Arch Pharm (Weinheim); 2011 Jul; 344(7):415-21. PubMed ID: 21598296
[TBL] [Abstract][Full Text] [Related]
29. Tetrahydro-3-benzazepines with fluorinated side chains as NMDA and σ
Thum S; Schepmann D; Ayet E; Pujol M; Nieto FR; Ametamey SM; Wünsch B
Eur J Med Chem; 2019 Sep; 177():47-62. PubMed ID: 31129453
[TBL] [Abstract][Full Text] [Related]
30. Cyclopenta[d]pyrimidines and dihydropyrrolo[2,3-d]pyrimidines as potent and selective corticotropin-releasing factor 1 receptor antagonists.
Arban R; Benedetti R; Bonanomi G; Capelli AM; Castiglioni E; Contini S; Degiorgis F; Di Felice P; Donati D; Fazzolari E; Gentile G; Marchionni C; Marchioro C; Messina F; Micheli F; Oliosi B; Pavone F; Pasquarello A; Perini B; Rinaldi M; Sabbatini FM; Vitulli G; Zarantonello P; Di Fabio R; St-Denis Y
ChemMedChem; 2007 Apr; 2(4):528-40. PubMed ID: 17335099
[TBL] [Abstract][Full Text] [Related]
31. Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A
Varano F; Catarzi D; Vincenzi F; Betti M; Falsini M; Ravani A; Borea PA; Colotta V; Varani K
J Med Chem; 2016 Dec; 59(23):10564-10576. PubMed ID: 27933962
[TBL] [Abstract][Full Text] [Related]
32. Chemoenzymatic synthesis of 2,6-disubstituted tetrahydropyrans with high σ
Kopp N; Civenni G; Marson D; Laurini E; Pricl S; Catapano CV; Humpf HU; Almansa C; Nieto FR; Schepmann D; Wünsch B
Eur J Med Chem; 2021 Jul; 219():113443. PubMed ID: 33901806
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and receptor binding studies of novel 4,4-disubstituted arylalkyl/arylalkylsulfonyl piperazine and piperidine-based derivatives as a new class of σ1 ligands.
Sadeghzadeh M; Sheibani S; Ghandi M; Daha FJ; Amanlou M; Arjmand M; Hasani Bozcheloie A
Eur J Med Chem; 2013 Jun; 64():488-97. PubMed ID: 23680866
[TBL] [Abstract][Full Text] [Related]
34. Synthesis pharmacological evaluation and docking studies of pyrimidine derivatives.
Giles D; Roopa K; Sheeba FR; Gurubasavarajaswamy PM; Divakar G; Vidhya T
Eur J Med Chem; 2012 Dec; 58():478-84. PubMed ID: 23159805
[TBL] [Abstract][Full Text] [Related]
35. Novel
Turnaturi R; Chiechio S; Pasquinucci L; Spoto S; Costanzo G; Dichiara M; Piana S; Grasso M; Amata E; Marrazzo A; Parenti C
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014375
[TBL] [Abstract][Full Text] [Related]
36. 4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane Derivatives as Dual μ-Opioid Receptor Agonists and σ
García M; Virgili M; Alonso M; Alegret C; Fernández B; Port A; Pascual R; Monroy X; Vidal-Torres A; Serafini MT; Vela JM; Almansa C
J Med Chem; 2020 Mar; 63(5):2434-2454. PubMed ID: 31743642
[TBL] [Abstract][Full Text] [Related]
37. Discovery of novel 6,6-heterocycles as transient receptor potential vanilloid (TRPV1) antagonists.
Blum CA; Caldwell T; Zheng X; Bakthavatchalam R; Capitosti S; Brielmann H; De Lombaert S; Kershaw MT; Matson D; Krause JE; Cortright D; Crandall M; Martin WJ; Murphy BA; Boyce S; Jones AB; Mason G; Rycroft W; Perrett H; Conley R; Burnaby-Davies N; Chenard BL; Hodgetts KJ
J Med Chem; 2010 Apr; 53(8):3330-48. PubMed ID: 20307063
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological and metabolic characterisation of the potent sigma1 receptor ligand 1'-benzyl-3-methoxy-3H-spiro[[2]benzofuran-1,4'-piperidine].
Wiese C; Grosse Maestrup E; Schepmann D; Vela JM; Holenz J; Buschmann H; Wünsch B
J Pharm Pharmacol; 2009 May; 61(5):631-40. PubMed ID: 19406002
[TBL] [Abstract][Full Text] [Related]
39. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
Müller CE; Geis U; Grahner B; Lanzner W; Eger K
J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
[TBL] [Abstract][Full Text] [Related]
40. Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring.
Bonifazi A; Del Bello F; Mammoli V; Piergentili A; Petrelli R; Cimarelli C; Pellei M; Schepmann D; Wünsch B; Barocelli E; Bertoni S; Flammini L; Amantini C; Nabissi M; Santoni G; Vistoli G; Quaglia W
J Med Chem; 2015 Nov; 58(21):8601-15. PubMed ID: 26430967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
